Drugs Controller General of India

Timelines
DRDO's anti-coronavirus drug cleared for emergency use by DCGI

08 May 2021

DRDO's anti-coronavirus drug cleared for emergency use by DCGI

The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-coronavirus drug developed by a laboratory of the Defence Research and Development Organisation (DRDO) to treat moderate to severe patients, reports say.

Panel recommends permission for Phase I Intranasal COVID-19 vaccine trial

20 Jan 2021

Panel recommends permission for Phase I Intranasal COVID-19 vaccine trial

An expert panel, Central Drugs Standard Control Organisation, (CDSCO) on Tuesday recommended granting permission for conducting the Phase I clinical trial of an intranasal vaccine against COVID-19 developed by Bharat Biotech, official sources said.

Sleeves up! Coronavirus vaccination drive could begin on January 13

05 Jan 2021

Sleeves up! Coronavirus vaccination drive could begin on January 13

The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.

SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

05 Jan 2021

SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

All you need to know about vaccines approved in India

03 Jan 2021

All you need to know about vaccines approved in India

Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.

SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI

03 Jan 2021

SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI

Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.

Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod

03 Jan 2021

Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod

A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.

All states to hold dry run for coronavirus vaccination today

02 Jan 2021

All states to hold dry run for coronavirus vaccination today

A dry run for vaccination, before the actual doses of the coronavirus vaccine are administered to people, will be held in all states and union territories today.

India set to start COVID-19 vaccination; panel approves Oxford vaccine

01 Jan 2021

India set to start COVID-19 vaccination; panel approves Oxford vaccine

In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.

India could start 2021 with COVID-19 vaccine in hand: DCGI

31 Dec 2020

India could start 2021 with COVID-19 vaccine in hand: DCGI

The approval for a COVID-19 vaccine in India is likely just around the corner, with the Drugs Controller General of India, Dr. VG Somani, indicating the country might begin the New Year with a vaccine in hand.

Now, Bharat Biotech seeks emergency use approval for COVAXIN

08 Dec 2020

Now, Bharat Biotech seeks emergency use approval for COVAXIN

After US-based Pfizer and Pune's Serum Institute of India, Bharat Biotech has sought an emergency use approval for its coronavirus vaccine, named COVAXIN.

Pfizer seeks emergency approval for COVID-19 vaccine in India

06 Dec 2020

Pfizer seeks emergency approval for COVID-19 vaccine in India

United States-based pharmaceutical giant Pfizer has sought emergency approval for its COVID-19 vaccine from India's drug regulator.

AIIMS to submit proposal for COVAXIN's phase three trials soon

31 Oct 2020

AIIMS to submit proposal for COVAXIN's phase three trials soon

By early next week, AIIMS will submit a proposal to start the third phase of clinical trials of COVAXIN, a vaccine against coronavirus being developed by Bharat Biotech.

Oxford's coronavirus vaccine could be available by December: Adar Poonawalla

29 Oct 2020

Oxford's coronavirus vaccine could be available by December: Adar Poonawalla

In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.

Bharat Biotech signs deal for nasal COVID-19 vaccine: Details here

23 Sep 2020

Bharat Biotech signs deal for nasal COVID-19 vaccine: Details here

In a major move, Bharat Biotech has signed an agreement to license a nasal COVID-19 vaccine developed by the Washington University School of Medicine in St. Louis, United States.

NewsBytes Briefing: China won't approve TikTok deal, and more

23 Sep 2020

NewsBytes Briefing: China won't approve TikTok deal, and more

Even as TikTok, Oracle, and Walmart came close to finalizing a deal, China is not ready to let the service off the hook.

Coronavirus: What is the 'Feluda' test? How does it work?

21 Sep 2020

Coronavirus: What is the 'Feluda' test? How does it work?

The Drugs Controller General of India (DCGI) has approved for commercial launch of a CRISPR-based test for COVID-19, called 'Feluda'.

SII gets nod for Oxford COVID vaccine phase 2/3 trials

03 Aug 2020

SII gets nod for Oxford COVID vaccine phase 2/3 trials

The Serum Institute of India (SII) has gotten the approval to conduct phase 2 and 3 human clinical trials of the COVID-19 vaccine candidate developed by Oxford University.

Expert panel sets conditions, ICMR's COVAXIN August-15 target looks unachievable

07 Jul 2020

Expert panel sets conditions, ICMR's COVAXIN August-15 target looks unachievable

On July 2, the Indian Council of Medical Research (ICMR) revealed its plans to launch COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech and ICMR, by August 15.

India's second COVID-19 vaccine cleared for human trials: Details here

03 Jul 2020

India's second COVID-19 vaccine cleared for human trials: Details here

India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.

Glenmark launches COVID-19 drug FabiFlu at Rs. 103 per tablet

20 Jun 2020

Glenmark launches COVID-19 drug FabiFlu at Rs. 103 per tablet

Glenmark Pharmaceuticals Ltd. launched the antiviral drug favipiravir on Saturday for the treatment of mild to moderate cases of COVID-19.

Remdesivir reportedly approved for COVID-19 treatment in India

02 Jun 2020

Remdesivir reportedly approved for COVID-19 treatment in India

Remdesivir has been approved by India's top drug regulator for "restricted emergency use" on COVID-19-infected adults and children.

GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance

26 Sep 2019

GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance

Amid an ongoing probe into Ranitidine's reported cancer-causing impurities, GlaxoSmithKline Pharmaceuticals Limited (GSK) has recalled Ranitidine-based antacid Zinetac (150mg and 300mg) in India and other markets.

'Vegetarian' capsules: Government forwards controversial proposal to scientific panel

29 Jun 2017

'Vegetarian' capsules: Government forwards controversial proposal to scientific panel

For the benefit of vegetarians, the government is considering substituting animal-based gelatin coating on capsules with plant cellulose.

Deep nexus: Swiss firm Roche allegedly blocked cheaper cancer drugs

28 Apr 2017

Deep nexus: Swiss firm Roche allegedly blocked cheaper cancer drugs

Competition Commission of India, the country's anti-trust regulator, has ordered a probe against Swiss drug maker Roche, which was allegedly attempting to maintain monopoly in the breast cancer drug market.